Kalberg C - Search Results

1

Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.

Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA. Rosenthal RR, et al. Among authors: kalberg c. Chest. 1999 Sep;116(3):595-602. doi: 10.1378/chest.116.3.595. Chest. 1999. PMID: 10492259 Clinical Trial.

2

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations.

Matz J, Emmett A, Rickard K, Kalberg C. Matz J, et al. Among authors: kalberg c. J Allergy Clin Immunol. 2001 May;107(5):783-9. doi: 10.1067/mai.2001.114709. J Allergy Clin Immunol. 2001. PMID: 11344343 Clinical Trial.

3

The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD.

Hanania NA, Kalberg C, Yates J, Emmett A, Horstman D, Knobil K. Hanania NA, et al. Among authors: kalberg c. Pulm Pharmacol Ther. 2005;18(1):19-22. doi: 10.1016/j.pupt.2004.07.005. Pulm Pharmacol Ther. 2005. PMID: 15607123 Clinical Trial.

4

Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.

Nelson HS, Nathan RA, Kalberg C, Yancey SW, Rickard KA. Nelson HS, et al. Among authors: kalberg c. MedGenMed. 2001 Jul 5;3(4):3. MedGenMed. 2001. PMID: 11549982 Clinical Trial.

5

Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone.

Calhoun WJ, Nelson HS, Nathan RA, Pepsin PJ, Kalberg C, Emmett A, Rickard KA, Dorinsky P. Calhoun WJ, et al. Among authors: kalberg c. Am J Respir Crit Care Med. 2001 Sep 1;164(5):759-63. doi: 10.1164/ajrccm.164.5.2012124. Am J Respir Crit Care Med. 2001. PMID: 11549529 Clinical Trial.

6

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma.

Bleecker ER, Welch MJ, Weinstein SF, Kalberg C, Johnson M, Edwards L, Rickard KA. Bleecker ER, et al. Among authors: kalberg c. J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1123-9. doi: 10.1067/mai.2000.106043. J Allergy Clin Immunol. 2000. PMID: 10856145 Clinical Trial.

7

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.

Busse W, Nelson H, Wolfe J, Kalberg C, Yancey SW, Rickard KA. Busse W, et al. Among authors: kalberg c. J Allergy Clin Immunol. 1999 Jun;103(6):1075-80. doi: 10.1016/s0091-6749(99)70182-x. J Allergy Clin Immunol. 1999. PMID: 10359889 Clinical Trial.

8

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.

Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K. Condemi JJ, et al. Among authors: kalberg c. Ann Allergy Asthma Immunol. 1999 Apr;82(4):383-9. doi: 10.1016/s1081-1206(10)63288-7. Ann Allergy Asthma Immunol. 1999. PMID: 10227337 Clinical Trial.

9

Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.

Kemp JP, Cook DA, Incaudo GA, Corren J, Kalberg C, Emmett A, Cox FM, Rickard K. Kemp JP, et al. Among authors: kalberg c. J Allergy Clin Immunol. 1998 Feb;101(2 Pt 1):188-95. doi: 10.1016/s0091-6749(98)70383-5. J Allergy Clin Immunol. 1998. PMID: 9500751 Clinical Trial.

10

Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.

Wenzel SE, Lumry W, Manning M, Kalberg C, Cox F, Emmett A, Rickard K. Wenzel SE, et al. Among authors: kalberg c. Ann Allergy Asthma Immunol. 1998 Jun;80(6):463-70. doi: 10.1016/S1081-1206(10)63068-2. Ann Allergy Asthma Immunol. 1998. PMID: 9647268 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results